Evidence map›Paper›PMID 36792227›Full record

ArticleBMJ global health2023

Cost-effectiveness of tuberculosis infection prevention and control interventions in South African clinics: a model-based economic evaluation informed by complexity science methods.

Fiammetta Maria Bozzani, Nicky McCreesh, Karin Diaconu, Indira Govender, Richard G White, Karina Kielmann, Alison D Grant, Anna Vassall

Open access · goldAbstract read
In one paragraph

Article in BMJ global health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Fiammetta Maria BozzaniDepartment of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK fiammetta.bozzani@lshtm.ac.uk.ORCID 0000-0002-9518-6885
Nicky McCreeshTB Centre, London School of Hygiene & Tropical Medicine, London, UK.ORCID 0000-0003-1409-8531
Karin DiaconuInstitute of Global Health and Development, Queen Margaret University Edinburgh, Musselburgh, UK.
Indira GovenderTB Centre, London School of Hygiene & Tropical Medicine, London, UK.
Richard G WhiteTB Centre, London School of Hygiene & Tropical Medicine, London, UK.ORCID 0000-0003-4410-6635
Karina KielmannInstitute of Global Health and Development, Queen Margaret University Edinburgh, Musselburgh, UK.ORCID 0000-0001-5519-1658
Alison D GrantTB Centre, London School of Hygiene & Tropical Medicine, London, UK.
Anna VassallDepartment of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK.
London School of Hygiene & Tropical Medicine · GBQueen Margaret University · GB

Funding

Defining drivers of TB transmission in the era of universal ART, and implications for finding the walking wellR01AI147321 · NIAID · LONDON SCH/HYGIENE & TROPICAL MEDICINE · PI GRANT, ALISON · 2019 to 2024
$2.3M
Medical Research Council CCF17-7779NIAID NIH HHS R01 AI147321Wellcome TrustWellcome Trust 218261/Z/19/Z
6 · The paper itself

Abstract

introductionNosocomial

methodsA set of TB IPC interventions was codesigned with local stakeholders using system dynamics modelling techniques that addressed both core activities and enabling actions to support implementation. An economic evaluation of these interventions was conducted at two clinics in KwaZulu-Natal, employing agent-based models of

resultsAll intervention scenarios modelled, inclusive of the relevant enablers, cost less than US$200 per disability-adjusted life-year (DALY) averted and were very cost-effective in comparison to South Africa's opportunity cost-based threshold (US$3200 per DALY averted). Two interventions, building modifications to improve ventilation and maximising use of the existing Central Chronic Medicines Dispensing and Distribution system to reduce the number of clinic attendees, were found to be cost saving over the 10-year model time horizon. Incremental cost-effectiveness ratios were sensitive to assumptions on baseline clinic ventilation rates, the prevalence of infectious TB in clinic attendees and future HIV incidence but remained highly cost-effective under all uncertainty analysis scenarios.

conclusionTB IPC interventions in clinics, including the enabling actions to ensure their feasibility, afford very good value for money and should be prioritised for implementation within the South African health system.

Indexed as

HIV InfectionsMycobacterium tuberculosisTuberculosisCost-Benefit AnalysisHumansSouth AfricaControl strategiesHealth economicsTuberculosis

Identifiers

PMID36792227
PMCPMC9933667
OpenAlexW4320914723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.